{"id":"NCT00384059","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","briefTitle":"Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants","officialTitle":"A Phase 3, Randomized, Active-Controlled, Double-Blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With Routine Pediatric Vaccinations in the United Kingdom","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-10","primaryCompletion":"2008-10","completion":"2008-10","firstPosted":"2006-10-04","resultsPosted":"2012-08-15","lastUpdate":"2013-01-24"},"enrollment":286,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Vaccines, Pneumococcal"],"interventions":[{"type":"BIOLOGICAL","name":"13-valent Pneumococcal Conjugate Vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"7vPnC","otherNames":[]},{"type":"BIOLOGICAL","name":"Pediacel","otherNames":[]},{"type":"BIOLOGICAL","name":"NeisVac-C","otherNames":[]},{"type":"BIOLOGICAL","name":"Menitorix","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to Prevenar (7vPnC), when given concomitantly with routine paediatric vaccines in the United Kingdom.","primaryOutcome":{"measure":"Percentage of Participants Achieving a Meningococcal C Serum Bactericidal Assay (SBA) Titer â‰¥1:8 and Predefined Antibody Levels for Pertussis and Haemophilus Influenzae Type b in 13vPnC Group Relative to 7vPnC Group After the 2-dose Infant Series.","timeFrame":"One month after infant series dose 2 (5 months of age)","effectByArm":[{"arm":"13vPnC","deltaMin":99.2,"sd":null},{"arm":"7vPnC","deltaMin":99.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"42 Days","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":11,"countries":["United Kingdom"]},"refs":{"pmids":["23965217","21155091"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":139},"commonTop":["Irritability","Increased sleep","Tenderness (Any)","Irritability","Decreased appetite"]}}